152 related articles for article (PubMed ID: 36106517)
1. Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen.
Gotoh M; Kurokawa T; Yonekura S; Okano M; Maekawa Y; Okamoto Y; Okubo K
Allergy; 2023 Feb; 78(2):563-568. PubMed ID: 36106517
[No Abstract] [Full Text] [Related]
2. [A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD].
Oka A; Yuta A; Okawa Y; Masuno S; Tsunoda T; Takahara E; Terada A; Kanai K; Nagakura H; Mimura H; Arao H; Ueyama S; Ueyama A; Tokuda R; Bamba H; Nakazato H; Nakazato M; Amesara R; Nakai S; Araki S; Sakaida M; Tokuriki M; Hama T; Chiba M; Ikeda H; Togawa A; Tsuzuki H; Hyo Y; Niitsu S; Ohkawa C; Nakamoto S; Takeo T; Kumanomidou H; Kanai K; Kitamura H; Sugiura R; Okano M
Arerugi; 2023; 72(9):1138-1146. PubMed ID: 37967960
[TBL] [Abstract][Full Text] [Related]
3. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS].
Yuta A; Ogawa Y; Kozaki H; Shimizu T
Arerugi; 2023; 72(10):1230-1239. PubMed ID: 38092399
[TBL] [Abstract][Full Text] [Related]
4. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
Yonekura S; Gotoh M; Okano M; Kurokawa T; Maekawa Y; Okubo K; Okamoto Y
Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
[No Abstract] [Full Text] [Related]
5. Allergen Stability and Immunological Reactivity during Co-dissolution and Incubation of House Dust Mite and Japanese Cedar Pollen SLIT-Tablets.
Watanabe A; Yamamoto T; Matsuhara H; Matsui H; Nakazawa H; Lund K; Ohashi-Doi K
Biol Pharm Bull; 2020 Oct; 43(10):1448-1450. PubMed ID: 32759600
[TBL] [Abstract][Full Text] [Related]
6. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
7. Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
Fujii T; Kitamura Y; Kamimura S; Takeda N
J Med Invest; 2022; 69(1.2):97-100. PubMed ID: 35466153
[TBL] [Abstract][Full Text] [Related]
8. Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets.
Yonekura S; Gotoh M; Kaneko S; Maekawa Y; Okubo K; Okamoto Y
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4103-4116.e14. PubMed ID: 34333190
[TBL] [Abstract][Full Text] [Related]
9. Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment.
Osada T; Okano M
Allergol Int; 2021 Jul; 70(3):281-290. PubMed ID: 33962864
[TBL] [Abstract][Full Text] [Related]
10. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
Ueda S; Ito J; Harada N; Harada S; Sasano H; Sandhu Y; Tanabe Y; Abe S; Shiota S; Kodama Y; Nagaoka T; Makino F; Chiba A; Akiba H; Atsuta R; Miyake S; Takahashi K
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454107
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis.
Kurokawa T; Yonekura S; Gotoh M; Okano M; Maekawa Y; Okubo K; Okamoto Y
J Allergy Clin Immunol Glob; 2023 May; 2(2):100075. PubMed ID: 37780797
[TBL] [Abstract][Full Text] [Related]
13. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
Yonekura S; Gotoh M; Kaneko S; Kanazawa K; Takeuji Y; Okubo K; Okamoto Y
Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
[TBL] [Abstract][Full Text] [Related]
14. Japanese Cedar Pollen Allergens in Japan.
Ohashi-Doi K; Utsumi D; Mitobe Y; Fujinami K
Curr Protein Pept Sci; 2022; 23(12):837-850. PubMed ID: 36200245
[TBL] [Abstract][Full Text] [Related]
15. Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis.
Waserman S; Shah A; Avilla E
Ann Allergy Asthma Immunol; 2021 Aug; 127(2):165-175.e1. PubMed ID: 34029713
[TBL] [Abstract][Full Text] [Related]
16. [ENHANCED CLINICAL EFFECTS OF CEDARCURE
Yuta A; Ogawa Y; Murao T; Kozaki H; Shimizu T
Arerugi; 2022; 71(9):1122-1128. PubMed ID: 36372423
[TBL] [Abstract][Full Text] [Related]
17. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T
Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
[TBL] [Abstract][Full Text] [Related]
18. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
Gotoh M; Okubo K; Yuta A; Ogawa Y; Nagakura H; Ueyama S; Ueyama T; Kawashima K; Yamamoto M; Fujieda S; Sakashita M; Sakamoto H; Iwasaki N; Mori E; Endo T; Ohta N; Kitazawa H; Okano M; Asako M; Takada M; Terada T; Inaka Y; Yonekura S; Matsuoka T; Kaneko S; Hata H; Hijikata N; Tanaka H; Masuyama K; Okamoto Y
Allergol Int; 2020 Jan; 69(1):104-110. PubMed ID: 31421989
[TBL] [Abstract][Full Text] [Related]
19. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy decreases the avidity of antigen-specific IgE in patients with Japanese cedar pollinosis.
Nakamura K; Kouzaki H; Murao T; Kawakita K; Arai H; Matsumoto K; Kubo Y; Tojima I; Shimizu S; Ogawa Y; Yuta A; Sakai R; Ohno H; Kido H; Shimizu T
Allergy; 2023 Dec; 78(12):3268-3271. PubMed ID: 37807665
[No Abstract] [Full Text] [Related]
[Next] [New Search]